Your search returned 7 results.

Results
	1.	Effect of infliximab on health-related quality of life and disease activity by body region in patients with moderate-to-severe psoriasis and inadequate response to etanercept: results from the PSUNRISE trial. [electronic resource] by Kalb, Robert E Blauvelt, Andrew Sofen, Howard L Chevrier, Marc Amato, David Calabro, Stephen Wang, Jim Schenkel, Brad Gottlieb, Alice B Producer: 20140505 In: Journal of drugs in dermatology : JDD vol. 12 Availability: No items available. Save to lists Add to cart (remove)
	2.	Safety Surveillance for Ustekinumab and Other Psoriasis Treatments From the Psoriasis Longitudinal Assessment and Registry (PSOLAR). [electronic resource] by Papp, Kim Gottlieb, Alice B Naldi, Luigi Pariser, David Ho, Vincent Goyal, Kavitha Fakharzadeh, Steven Chevrier, Marc Calabro, Stephen Langholff, Wayne Krueger, Gerald Producer: 20160418 In: Journal of drugs in dermatology : JDD vol. 14 Availability: No items available. Save to lists Add to cart (remove)
	3.	WITHDRAWN: Experience with ustekinumab in patients with psoriasis enrolled in a large, multicenter, prospective, disease-based registry (Psoriasis Longitudinal Assessment and Registry [PSOLAR]). [electronic resource] by Papp, Kim Gottlieb, Alice B Naldi, Luigi Pariser, David Ho, Vincent Goyal, Kavitha Fakharzadeh, Steven Chevrier, Marc Calabro, Stephen Langholff, Wayne Krueger, Gerald Publication details: Journal of the American Academy of Dermatology Jan 2015 In: Journal of the American Academy of Dermatology Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	The efficacy and safety of infliximab in patients with plaque psoriasis who had an inadequate response to etanercept: results of a prospective, multicenter, open-label study. [electronic resource] by Gottlieb, Alice B Kalb, Robert E Blauvelt, Andrew Heffernan, Michael P Sofen, Howard L Ferris, Laura Korb Kerdel, Francisco A Calabro, Stephen Wang, Jim Kerkmann, Urs Chevrier, Marc Producer: 20121127 In: Journal of the American Academy of Dermatology vol. 67 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis: Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR). [electronic resource] by Kalb, Robert E Fiorentino, David F Lebwohl, Mark G Toole, John Poulin, Yves Cohen, Arnon D Goyal, Kavitha Fakharzadeh, Steven Calabro, Stephen Chevrier, Marc Langholff, Wayne You, Yin Leonardi, Craig L Producer: 20151215 In: JAMA dermatology vol. 151 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Safety observations in 12095 patients with psoriasis enrolled in an international registry (PSOLAR): experience with infliximab and other systemic and biologic therapies. [electronic resource] by Gottlieb, Alice B Kalb, Robert E Langley, Richard G Krueger, Gerald G de Jong, Elke M G J Guenther, Lynn Goyal, Kavitha Fakharzadeh, Steven Chevrier, Marc Calabro, Stephen Langholff, Wayne Menter, Alan Producer: 20150928 In: Journal of drugs in dermatology : JDD vol. 13 Availability: No items available. Save to lists Add to cart (remove)
	7.	Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR]). [electronic resource] by Strober, Bruce E Bissonnette, Robert Fiorentino, David Kimball, Alexa B Naldi, Luigi Shear, Neil H Goyal, Kavitha Fakharzadeh, Steven Calabro, Stephen Langholff, Wayne You, Yin Galindo, Claudia Lee, Seina Lebwohl, Mark G Producer: 20160902 In: Journal of the American Academy of Dermatology vol. 74 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)